TRPM2 and endometrial cancer: The subsequent rescue experiments showed that the inhibitory impacts of TRPM2-AS knockdown on growth and metastasis of endometrial cancer, were attenuated by miR-424-5p downregulation or PDIA6 overexpression both in phenotype and protein molecular level.